Pharmaceutical tablet manufacturer wanted in Europe

The buyer is a pharmaceutical and biotechnology company, based in EU, manufacturing over 250 products offered to patients around the world. The products are marketed in nearly 60 countries in Europe, including Middle East, Asia, Africa, Latin America and Australia. Affiliates and representative offices are established already in more than 5 countries of Europe. The company has over 30 years of a history of profitable growth in European markets as well as a successful track record in developing license-out business. 

The company is focused on multiple therapeutic areas, including cardiology, oncology, pulmonology, dermatology, gynaecology, urology, ophthalmology, angiology, psychiatry, allergology, gastroenterology, rheumatology, etc.

The buyer company focuses strongly on research and development, owning over 90 patents in generic and innovative products. The company has scientific research partnerships with leading universities and institutes, over 150 scientists collaborating with the buyer on the research of effective therapies.

The company has a history of more than 30 years, successfully growing until today, with two production facilities in Europe. The company had acquired multiple targets in last 10 years in the pharma sector. The production facilities have cGMP certifications and implemented methods like Kaizen, TMP / SPED etc. The buyer has a revenue of more than 150M EUR, constantly growing by >5% per year.

The target should be a tablet manufacturing facility or operate in similar production. The buyer requires the target to have GMP standard and all other necessary licenses and certifications.

It is also preferred for the target to be active in following markets (but not compulsory):

The management is, however, open to receive investment opportunities from all countries of Europe, in all sizes.